Anne-Laure Pelletier

Statistics

Publications

Citations

1.4K

H-Index

Active since

1985

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Hôpital Bichat-Claude-Bernard

Université Paris Cité

Inserm

Sorbonne Université

Anne-Laure Pelletier is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, gastroenterology, and inflammatory bowel disease.

ORCID

Publications per year

1985–2023

Publications

Pancreas Divisum Is Not a Cause of Pancreatitis by Itself But Acts as a Partner of Genetic Mutations

Caroline Bertin, Anne-Laure Pelletier, Marie‐Pierre Vullierme et al. · The American Journal of Gastroenterology · 2011 · 250 citations

Medicine, Molecular Genetics, Pathology +16

One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study

Aurélien Amiot, Mélanie Serrero, Laurent Peyrin‐Biroulet et al. · Alimentary Pharmacology & Therapeutics · 2017 · 177 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?

Driffa Moussata, Matthieu Allez, Dominique Cazals‐Hatem et al. · Gut · 2017 · 167 citations

Medicine, Clinical Sciences, Pathology +17

Cirrhotic patients with portal hypertension-related bleeding and an indication for early-TIPS: A large multicentre audit with real-life results

Dominique Thabut, Arnaud Pauwels, Nicolas Carbonell et al. · Journal of Hepatology · 2017 · 125 citations

Medicine, Internal Medicine, Surgery +13

Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the <scp>OBSERV</scp>‐<scp>IBD</scp> cohort

S. Tadbiri, Laurent Peyrin‐Biroulet, Mélanie Serrero et al. · Alimentary Pharmacology & Therapeutics · 2017 · 112 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

1–5 of 26